Aldeyra Therapeutics Inc
ALDX
Get informed when a big investor buys or sells
+ FollowMarket Cap$110.39M
Close$
$0.91
60% downside
Current Fair Value
60% downsideOvervalued by 60% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $110.39 Million |
|---|---|
| Enterprise Value | $-43,489,425,612,446.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.56 |
| Beta | 1.19 |
| Outstanding Shares | 60,319,000 |
Return
| Return on Equity | -49.60% |
|---|---|
| Return on Assets | -31.45% |
| Return on Invested Capital | -51.51% |
Valuation & Multiples
| P/E Ratio | -4 |
|---|---|
| PEG | 0 |
| Price to Sales | - |
| Price to Book Ratio | 0.0 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 2 |
| Enterprise Value to Net Income | 2 |
| Total Debt to Enterprise | -0.49 |
| Debt to Equity | 0.51 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 13, 2026
EPS Estimate
$-0.13
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 6, 2026
EPS Estimate
$-0.11
Average shareholder expectationRevenue Estimate
$31.33 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.5099▲ 20.79% |
|---|---|
| Total Calls | 640,100▲ 2.24% |
| Total Puts | 326,400▲ 72.61% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 62.02%▼ 2.78% |
|---|---|
| Total Invested | $63.29M▼ 68.63% |
| Investors Holding | 133▼ 11.00% |
ESG Score
No data